The Daily Delta - Canadian AML & Financial Crime News - September 16, 2026
The Daily Delta

The Daily Delta - Canadian AML & Financial Crime News
September 16, 2026

Featured
International Consortium of Investigative Journalists
ICIJ reports that the Industrial and Commercial Bank of China (ICBC) promoted senior executive Zhang Hongli and expanded internationally despite earlier allegations of misconduct and persistent internal governance concerns. Deutsche Bank had accused Zhang in a 2014 civil claim of improperly transferring US$3.9 million to a relative’s consulting company, yet ICBC later promoted him to executive director; Chinese authorities subsequently investigated him for corruption and a court convicted him of taking more than US$24 million in bribes, imposing a suspended death sentence in 2025. Confidential ICBC records reviewed by ICIJ also describe recurring employee fraud, bribery concerns, suspicious account activity, weak AML controls and failures to supervise overseas staff, including internal findings that some employees deposited large sums of unknown origin for clients and approved suspicious mortgage loans. ICIJ says ICBC’s own internal reviews acknowledged that a robust compliance culture had not been established across parts of its international operations.
Read more →
Key Developments

Independent AML Effectiveness Reviews
AlphaDelta helps Canadian reporting entities complete required two-year AML effectiveness reviews that are practical, defensible, and aligned to FINTRAC expectations.

Every review includes a 90-day findings clarification session and our 12-month FINTRAC examination support commitment.
Get the weekly recap of the developments shaping AML, sanctions, fraud, and financial crime compliance. Add The Weekly Alpha to your email subscription →
Important Disclosure

The Daily Delta is a curated news briefing produced by AlphaDelta Advisory Group for informational purposes only. It is designed to help readers identify relevant regulatory, enforcement, financial crime, and compliance developments and to direct readers to the original source materials.

Article titles, publisher names, and source links are provided for attribution and reference. Summaries are prepared in AlphaDelta’s own wording, including through the use of automated tools, to provide brief, non-comprehensive descriptions of selected developments. They are not intended to reproduce, replace, or serve as a substitute for the original articles, publications, regulatory guidance, or source materials.

Summaries may omit context, nuance, limitations, author views, subsequent updates, or other information contained in the original source. Readers should review the linked source materials directly before making compliance, legal, operational, policy, or business decisions.

AlphaDelta does not verify, endorse, or guarantee the accuracy, completeness, availability, or timeliness of third-party content referenced in this briefing. All third-party content, trademarks, article titles, publisher names, and related rights remain the property of their respective owners. Reference to third-party materials does not imply endorsement, affiliation, sponsorship, or approval by the original publisher or issuing authority.

If a rights holder believes any reference, summary, or link should be modified or removed, they may contact AlphaDelta Advisory Group at info@alphadeltaadvisory.com for review.
© 2026 AlphaDelta Enterprises Inc. All rights reserved.

When was your last AML effectiveness review?

FINTRAC requires reporting entities to carry out and document an effectiveness review at least every two years.

If your next review is due or approaching, contact AlphaDelta today.
BOOK A REVIEW
© 2026 AlphaDelta Enterprises Inc., operating as AlphaDelta Advisory Group. All rights reserved. Canada.